Results 51 to 60 of about 10,171 (92)

Rare cases in two Chinese MEN2A families with RET C634Y germline mutation-a homozygous female patient and heterozygous identical twins: a systematic review of literature. [PDF]

Front Endocrinol (Lausanne)
Qi XP, Weng YT, Chen ZY, Zhang MX, Yang XL, Cao ZL, Zhang XX, Zhu WB, Yu HY, Chen WY, Chen JY, Li FP.   +11 more
europepmc   +1 more source

The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma. [PDF]

Endocr Relat Cancer
Kraft IL, Akshintala S, Gross A, Dombi E, Turkbey B, Bednarova S, Ward JF, Yedururi S, Merino M, Pinto PA, Widemann BC, Shern JF, Waguespack SG, Glod J.   +13 more
europepmc   +1 more source

Inhibitory Effects of Vandetanib on Catecholamine Synthesis in Rat Pheochromocytoma PC12 Cells. [PDF]

Int J Mol Sci
Itoh Y, Inagaki K, Terasaka T, Morimoto E, Ishii T, Yamaoka K, Fujisawa S, Wada J.   +7 more
europepmc   +1 more source

Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium. [PDF]

Clin Cancer Res
Waliany S, Cooper AJ, Liu SV, Gautschi O, Rotow JK, Smith KER, Weber UM, Lee DH, Loong HHF, Patel JD, Pennell NA, Nagasaka M, Patel SA, Tan DSW, Solomon BJ, Kim TM, Pall G, Riess JW, Sun L, Früh M, Uy NF, Gadgeel S, Feng J, Do A, Falcon C, Leighl NB, Baik CS, Lai GGY, Ou SI, Cheung KSY, Patil T, Mansfield AS, Weiler D, Yeap BY, Wirth LJ, Gainor JF, Drilon A, Lin JJ.   +37 more
europepmc   +1 more source

Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese. [PDF]

PLoS One
Li F, Chen W, Chen Z, Lian B, Fang X, Jin H, Wang H, Zhao J, Zhang Y, Qi X.   +9 more
europepmc   +1 more source

Vitamin D Deficiency Activates Gdnf-Ret-pErk1/2 Signal and Induces Kidney Malformations in Mice. [PDF]

Int J Mol Sci
Yu M, Ye N, Ju H, Miao Q, Wang C, Dai R, Chen J, Zhai Y, Sun L, Wu X, Xu H, Shen Q.   +11 more
europepmc   +1 more source

Molecular Pathology of Advanced NSCLC: Biomarkers and Therapeutic Decisions. [PDF]

Cancers (Basel)
Winter M, Jeroch J, Wetz M, Rauschendorf MA, Wild PJ.   +4 more
europepmc   +1 more source

Efficacy of selpercatinib as a first-line treatment for <i>RET</i>-fusion positive non-small-cell lung cancer: a novel two-stage Bayesian network meta-analysis. [PDF]

J Comp Eff Res
Forsyth JE, Khanal M, Kiiskinen U, Jyothi A, Goel R, Puri T, Ren S, Sonksen MD, Wang X, Jen MH.   +9 more
europepmc   +1 more source

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report. [PDF]

Medicine (Baltimore)
Breitenecker K, Fabikan H, Weinlinger C, Krenbek D, Klikovits T, Watzka S, Valipour A, Hochmair MJ.   +7 more
europepmc   +1 more source

State of the Art on Thyroid Cancer Biology and Oncology. [PDF]

Biomedicines
Vaio F, Moliterni C, Mardente S, Misasi R, Mari E.   +4 more
europepmc   +1 more source